Major pharma stocks drop 5%+ within 30 days of Trump plan

Within 30 days of the Trump administration's drug price affordability plan being announced, the share prices of at least three major pharmaceutical companies (e.g., Pfizer, Merck, Johnson & Johnson) will decline by 5% or more. This reflects investor concerns over reduced profit margins and revenue projections due to price controls.

Implied probability (Yes)

80%